BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 20575003)

  • 1. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids.
    Nimesh S; Gupta N; Chandra R
    J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
    Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
    Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
    Kuruba R; Wilson A; Gao X; Li S
    AAPS J; 2009 Mar; 11(1):23-30. PubMed ID: 19132538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid delivery for therapeutic applications.
    Gupta A; Andresen JL; Manan RS; Langer R
    Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery systems for oligonucleotide therapeutics.
    Yu B; Zhao X; Lee LJ; Lee RJ
    AAPS J; 2009 Mar; 11(1):195-203. PubMed ID: 19296227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee SH; Castagner B; Leroux JC
    Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
    Vetter VC; Wagner E
    J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current landscape of nucleic acid therapeutics.
    Kulkarni JA; Witzigmann D; Thomson SB; Chen S; Leavitt BR; Cullis PR; van der Meel R
    Nat Nanotechnol; 2021 Jun; 16(6):630-643. PubMed ID: 34059811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.
    Fattal E; Fay F
    Adv Drug Deliv Rev; 2021 Aug; 175():113809. PubMed ID: 34033819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.
    D'Souza A; Nozohouri S; Bleier BS; Amiji MM
    Pharm Res; 2023 Jan; 40(1):77-105. PubMed ID: 36380168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
    Gait MJ; Agrawal S
    Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled and nanostructured siRNA delivery systems.
    Jeong JH; Park TG; Kim SH
    Pharm Res; 2011 Sep; 28(9):2072-85. PubMed ID: 21424157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acids-based therapeutics in the battle against pathogenic viruses.
    Haasnoot J; Berkhout B
    Handb Exp Pharmacol; 2009; 189(189):243-63. PubMed ID: 19048203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
    Ashizawa AT; Cortes J
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review.
    Geinguenaud F; Guenin E; Lalatonne Y; Motte L
    ACS Chem Biol; 2016 May; 11(5):1180-91. PubMed ID: 26950048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the development of nucleic acid therapeutics for cancer.
    Kalota A; Shetzline SE; Gewirtz AM
    Cancer Biol Ther; 2004 Jan; 3(1):4-12. PubMed ID: 14726654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acids as therapeutic agents.
    Alvarez-Salas LM
    Curr Top Med Chem; 2008; 8(15):1379-404. PubMed ID: 18991725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.